BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20231493)

  • 21. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive features of melanoma and its management in elderly patients: a population-based study in France.
    Ciocan D; Barbe C; Aubin F; Granel-Brocard F; Lipsker D; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS; Grange F
    JAMA Dermatol; 2013 Oct; 149(10):1150-7. PubMed ID: 23945633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inpatient and outpatient follow-up of grade I malignant melanoma].
    Cordel N; Safa G; Balguerie X; De Preville P; Modeste A; Courville P; Boivin C; Pellerin A; Ziade J; Thiberville G; Laaengh-Michel N; Neveu C; Young P; Lauret P; Joly P
    Ann Dermatol Venereol; 2000; 127(6-7):579-83. PubMed ID: 10930854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thick melanoma: the problem continues.
    Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection.
    Roetzheim RG; Pal N; van Durme DJ; Wathington D; Ferrante JM; Gonzalez EC; Krischer JP
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):211-8. PubMed ID: 10906640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathological characteristics of melanoma: a population-based study in a French regional population.
    Barbe C; Hibon E; Vitry F; Le Clainche A; Grange F
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):159-64. PubMed ID: 21466590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospective epidemiological study on cutaneous melanomas in the Vendée area].
    Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1121-4. PubMed ID: 14724514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
    Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
    Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2006 Sep; 155(3):561-9. PubMed ID: 16911282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of a campaign to train general practitioners in screening for melanoma.
    Peuvrel L; Quereux G; Jumbou O; Sassolas B; Lequeux Y; Dreno B
    Eur J Cancer Prev; 2009 Jun; 18(3):225-9. PubMed ID: 19491609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in France.
    Grange F; Barbe C; Aubin F; Lipsker D; Granel-Brocard F; Velten M; Dalac S; Truchetet F; Michel C; Mitschler A; Arnoult G; Buemi A; Dalle S; Bernard P; Woronoff AS
    Arch Dermatol; 2012 Dec; 148(12):1370-6. PubMed ID: 22986518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous melanoma: public health approach to early detection.
    Weinstock MA
    Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas.
    Liu W; Dowling JP; Murray WK; McArthur GA; Thompson JF; Wolfe R; Kelly JW
    Arch Dermatol; 2006 Dec; 142(12):1551-8. PubMed ID: 17178980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine dermatologist-performed full-body skin examination and early melanoma detection.
    Kantor J; Kantor DE
    Arch Dermatol; 2009 Aug; 145(8):873-6. PubMed ID: 19687416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
    Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
    Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.